Home

Carl N Kraus

CIK 1946475 · Chief Medical Officer · last filed 2025-10-17

Carl N Kraus is a Chief Medical Officer who has filed 11 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing, for AQST, was dated Nov 17, 2025. Across all open-market trades the lifetime net is −$141.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.06M

Companies

3

Total Filings

11

Lifetime Open-Market Net

-$141.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AQST Chief Medical Officer 282,475 $3.76 $1.06M -$141.9K 6 2025-10-17
Aceragen, Inc. (ACGN) Delisted CHIEF MEDICAL OFFICER — $0.38 — $0 1 2023-02-02
Aceragen, Inc. (IDRA) Delisted Chief Medical Officer — $7.22 — $0 1 2022-09-30

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-11-17 AQST Notice (144) −53,100 -$286.2K EDGAR
2025-10-17 AQST Sell (S) −20,272 -$141.9K EDGAR
2025-10-15 AQST Notice (144) −40,544 -$278.9K EDGAR
2025-08-12 AQST Tax (F) −10,819 -$42.2K EDGAR
2025-03-11 AQST Mixed +61,885 -$21.5K EDGAR
2024-08-12 AQST Tax (F) −10,819 -$37.1K EDGAR
2024-03-11 AQST Grant (A) +112,500 $0 EDGAR
2023-08-09 AQST Grant (A) +150,000 $0 EDGAR
2023-02-02 Aceragen, Inc. (ACGN) Delisted Grant (A) — $0 EDGAR
2023-01-19 — Exer (M) — $0
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.